←
Alex Teng729 posts
Alex Teng avatar

Alex Teng

@Alexteng

helping founders make abundance the default @fiftyyears

◷ Joined October 2020▧ 22 Photos and videos
Alex Teng avatar
Alex Teng@Alexteng·6h

alchemists spent centuries trying to turn base materials into gold. kevin and caleb skipped gold and went for battery graphite instead. huge day for the team!

Over the last 18 months, the @Molten_Ind team has literally worked day and night to build and commission the world's first plant to turn natural gas into battery-grade graphite and clean hydrogen. Molten graphite delivers state-of-the-art performance, verified by leading global battery producers, with 3x less electricity and zero process emissions. 100% US-made and operating now at a modular commercial scale. @TechCrunch and the brilliant @tdechant have the story below

0:45
Alex Teng avatar
Alex Teng@Alexteng·19h

👀

In 1969, explorers drilled an Australian copper-gold deposit and wrote it off. 57 years later, @EarthAI has outlined a system stretching over 3km at Fontenoy, NSW Our new AI model, Alpheus, has flagged 4,500 more targets, giving us the potential to double the world’s mines 🧵

Post attachment
romanteslyuk avatar
⟳ Alex Teng retweeted
romanteslyuk@romanteslyuk·22h

In 1969, explorers drilled an Australian copper-gold deposit and wrote it off. 57 years later, @EarthAI has outlined a system stretching over 3km at Fontenoy, NSW Our new AI model, Alpheus, has flagged 4,500 more targets, giving us the potential to double the world’s mines 🧵

Post attachment
Alex Teng avatar
Alex Teng@Alexteng·Nov 17

if you do AI and want to RADICALLY SHORTEN drug discovery timelines, this is the team to join! ABSOLUTELY DREAM JOB IN BIO!!!

I’m looking for a special hire to help shape a core pillar of Manifold Bio: enabling powerful AI to create medicines. At Manifold, we've built a learning loop between AI drug design and biological reality. We can physically test millions of protein designs, including directly in living systems, and pair that capability with cutting-edge AI protein design (see our mBER-2 pre-print that set records in scale, epitope coverage, and novel formats). In short, we have the greatest throughput and lowest latency of data generation of molecules tested in relevant systems in the world. This is the engine behind our $2B collaboration with Roche with more coming soon. I’m calling the role Product Manager for AI Platform & Partnerships. The role reports directly to me. It spans strategy, engineering, business development, and alliance management with three core remits: - Shape our AI roadmap: prioritize what we build, design evals to steer system evolution, and help turn ideas into tools our scientists use. - Evolve our AI partnerships: identify opportunities, connect them to our capabilities, and turn them into joint projects and compelling demos. - Make our AI capabilities tangible: build interactive demos that show scientists and partners what’s possible, and help shape what we build next. I’m looking for someone with good instincts for how to seize this moment. You need to be able to work across scientists, engineers, and external partners. You should have opinions on how to best leverage AI systems, as well as what’s possible given the physical reality interface we’ve built. You should have a clear view on how the ecosystem is evolving, and a track-record of building apps or workflows using modern AI tools. A traditional PM background isn’t required. I’m looking for someone with deep curiosity, high slope, and a track record of moving matter and making things happen. Please reach out or find an intro to me directly.

Dileep George avatar
⟳ Alex Teng retweeted
Dileep George@dileeplearning·Oct 29

Compute is the helium of the AI era. In 1920, everyone bet on bigger, better balloons. You can fly without understanding aerodynamics, and you can get intelligent behavior without fully understanding intelligence. Talked dirigibles and brains with @fuelfive on Progress.

Why has no one cracked the brain? Progress ep10 is live with @dileeplearning, my Vicarious co-founder, now head of AI research at @AsteraInstitute. We discuss why today's AI is a dirigible, why scaling isn't enough, and whether rogue-AI stories are overhyped.

0:31
Alex Federation avatar
⟳ Alex Teng retweeted
Alex Federation@afederation·Oct 27

We opened the API and MCP for our structure-free drug discovery model (Ptarmigan-1) today. With that, we're also increasing usage limits by 1,000x In my first week of grad school I sat through a lecture on ‘undruggable’ targets, which ended up being a frustrating (but motivational) moment, and I've worked the last 15 trying to help remove this term from the trade. Ptarmigan-1 is a first step to let AI target these proteins, powered by native-cell data where these targets are at home. With the API/MCP, you (or your agent) can now rank up to 10M compounds against a protein using only its sequence, with no 3D structure predict where it will bind. That's ~10 GPU-years of co-folding

Post attachment
Jerry Tworek avatar
⟳ Alex Teng retweeted
Jerry Tworek@MillionInt·Sep 13

Alignment is not as hard to solve as many claim, but it is in the end an algorithmic problem which a lot of ML community mostly stopped working on. Formulation of alignment stated by three (or four) laws of robotics can take us very far, so we roughly know the objective. The tricky part is, how do we take gradient with respect to alignment? We have two algorithms right now at our disposal: pretraining and RL. Pretraining takes gradient with respect to next token prediction - that's def not the alignment objective. We could create RL environments that embody the alignment objective, but: - those are expensive to create, so often cheaper, hackable proxies are used in practice - RL as an objective needs successful and unsuccessful rollouts to happen to take the gradient step. We DO NOT want to harm any humans in the process of aligning our modes - this is a pretty big problem. Therefore there are two solutions forward for the alignment problem: - either we RL models in a simulated environments with simulated alignments and decreasing the likelihood of harming simulated humans, which will never be perfect - or we create a new algorithm that can teach our models to not harm humans without harming any humans in the process Science is the process how we solve the hardest problems ahead and that is one of them

✶ ela ✶ avatar
⟳ Alex Teng retweeted
✶ ela ✶@elamadej·Sep 12

my 1st reaction to news that @DarioAmodei @sama @elonmusk are agreeing to coordinate & slow the frontier development was tears of relief yes, the coordination might be minimal, the agreement might be strategic, incentives prevail... but we've been living though the lemur march long enough and this is hope. here to help if I can

Aalo Atomics avatar
⟳ Alex Teng retweeted
Aalo Atomics@AaloAtomics·Sep 2

"Few people realize that there is as much energy contained in US nuclear waste as there is in global known oil and gas reserves... we can extend the usable lifespan of nuclear fuel on Earth from one to two hundred years to millions of years." - Matt Loszak at Energy Subcommittee Hearing: Powering the Nuclear Renaissance:

0:35
Seth Bannon avatar
⟳ Alex Teng retweeted
Seth Bannon@sethbannon·Sep 1

Optimizing and making maximally efficient how we serve AI inference is going to be one of the defining problems of our time. Nobody is doing it better than @gpuemi, @gpusteve, and the @wafer_ai team.

i'm sad to announce that our recent fundraising round did not go according to plan... we initially planned to raise $18m. we didn't end up getting that number. we ended up raising a $40m series a instead. co-led by @MarathonMP and @chemistry, with participation from @Wing_VC, @AMD Ventures, @outsetcap, @fiftyyears, and @ycombinator, and our existing investors doubling down on @wafer_ai. we are also joined by an incredible list of angels, including @JeffDean (CEO, @DiscoLoopAI), @rauchg (CEO, @vercel), @andyfang (CTO, @DoorDash), @kvogt (CEO, Bot), @akothari (COO, @NotionHQ), @eastdakota (CEO, @Cloudflare), @deepgramscott (CEO, @DeepgramAI), and more. back to the kernel mines

Post attachment
Matt Loszak | Aalo Atomics avatar
⟳ Alex Teng retweeted
Matt Loszak | Aalo Atomics@MattLoszak·Aug 21

View of the Aalo Experimental Campus (Aalo-X) from the sky First new reactor facility at the Idaho National Lab in over 50 years

Post attachmentPost attachmentPost attachment
Martin Borch Jensen avatar
⟳ Alex Teng retweeted
Martin Borch Jensen@MartinBJensen·Aug 26

Wherein much progress for @gordianbio is reported. - In our current CRM focus, we've already got causal validation data on more targets than have been published by the entire industry in the past 20 years. - One partnership (with Pfizer) announced so far, as the machine continues to map every druggable target. - Meanwhile GOR-101, the dual-acting disease modifying drug from our osteoarthritis mapping, is heading towards the clinic. I left academia to avoid pinning all hope on a single hypothesis for longevity, and instead build a system that would inevitably find solutions to each way our bodies break with age. That system now exists.

Gordian Progress Report: Summer 2026 Our drug discovery machine has now captured the the effects of 1,327 targets in living diseased tissue across six disease areas, nearly the same number the global biomedical research community has reported over the past 20 years. It includes: - 352 in MASH - 304 in obesity - 290 in heart failure - 168 in osteoarthritis - 203 in PPF We just expanded to chronic kidney disease, and are on track to triple the number of targets with in vivo causal validation data by the end of next year. Instead of picking winners first and validating them later, we generate the evidence first and then pick the winners. We do this with Mosaic Screening, which lets us test hundreds of perturbations in living disease tissue, resolve their causal effects on disease at scale, and then select the best targets for conversion to drug candidates. This is how we found a new drug candidate for osteoarthritis, Omen 13, in a large mammal model of natural disease, and we're moving it into the clinic. As we apply the machine to more diseases, we can compare the causal maps between diseases to find potential multimorbidity drugs. See how our cure engine has grown in our Summer 2026 progress report here: blog.gordian.bio/p/gordian-p…

Post attachment
Atoms Not Bits avatar
⟳ Alex Teng retweeted
Atoms Not Bits@AtomsNotBits·Aug 25

EXCLUSIVE: 8VC leads $16M Lazarus round to build modular supercritical CO₂ turbines for America’s data center buildout. Today, @LazarusEnergy, the Hawthorne-based startup, has secured an oversubscribed $16M seed round led by @8vc, with additional investment from Marlinspike, DST Global, Neuron Power Ventures, and @relentless_inv, as well as follow-up investment from @fiftyyears and @sidedoor_vc. The company is betting that a new turbine architecture can help solve one of the biggest constraints on America’s data center buildout, power. Supercritical carbon dioxide could decide America’s AI sovereignty. CO₂ crosses into the supercritical phase above 31.1°C and 73.8 bar, where liquid and gas collapse into a single fluid with liquid-like density and gas-like flow. It plays a special role in closed-loop Brayton cycle turbines, which could become core to data center power generation. Turbines are becoming increasingly important for data centers as power demand exceeds grid capacity and operators look for reliable on-site power. The traditional turbine market is behind, with wait times exceeding 5 to 7 years and OEMs even turning down new orders because capacity is maxed out. Lazarus is attempting to shift the supply curve. The LA startup was founded by George Kitromelides (CEO) and Luke Malcolm (CTO), both formerly on the propulsion team at Anduril, alongside team members from Siemens Energy, Williams International, and Ursa Major. The startup is developing turbines that enable a forward-deployable power plant fitting inside a shipping container. “Supercritical CO₂ lets you reduce the size of your components significantly,” according to George Kitromelides (CEO), thus enabling the distributed form factor. Traditional turbines are optimized for specific heat sources. Lazarus designed its system to be heat-source agnostic, allowing it to convert heat from nearly any major energy source into electricity. Lazarus has created a natural edge. It can serve today’s data center market with proven inputs like natural gas while remaining positioned for future heat sources like small modular reactors. Deployment is another edge. Traditional turbine players can require months or years of construction to set up on-site, while Lazarus’ platform is fully assembled at its facility and requires zero on-site construction. In areas like nuclear, this can be key. Luke Malcolm (CTO) states, “SMRs are supposed to be compact, modular, deployable power. And when you build your compact reactor and then spend a year building all your steam infrastructure on-site, that kind of defeats the whole purpose.” Lazarus is focused on two end markets, data centers as the beachhead market and small modular nuclear reactors as the secondary market, both with unique business models. In the data center market, “The OEMs are straight up rejecting new orders. They’re turning customers away because they just can’t keep up with demand,” according to George Kitromelides (CEO). Lazarus wants to provide power-as-a-service in the data center market, where it would own and operate the asset instead of the data center operator incurring CapEx. Additionally, the own-and-operate/PPA model allows Lazarus to generate significantly more long-term revenue than a one-time equipment sale. Under a power purchase agreement (PPA), customers pay for the electricity generated by the system over time rather than purchasing the power infrastructure upfront. Lastly, behind-the-meter power is surging as data centers seek dedicated, off-grid generation to avoid grid delays and secure reliable power. Lazarus enables that by delivering compact on-site power systems built for data center demand. On the nuclear side, Lazarus would integrate with SMR companies to supply the power cycle, with nuclear heat going into the Lazarus cycle and electricity coming out. This model would focus on selling units to reactor companies, followed by multi-year maintenance contracts. Lazarus is developing a true picks-and-shovels play for the AI power gold rush. But the broader opportunity extends well beyond data centers. As the forward-deployed stack expands across compute, manufacturing, medical units, and logistics, compact containerized power could become critical infrastructure for Department of War installations, remote mining operations, disaster response, and any site where reliable power needs to move closer to the edge. The team of six full-time engineers is focused on firing a 1-megawatt sub-module of its system by late this year or early next year. The system will be powered by natural gas. Additionally, the startup has secured an MOU with a nuclear customer and has received strong interest from the data center market.

Post attachment
Matt Loszak | Aalo Atomics avatar
⟳ Alex Teng retweeted
Matt Loszak | Aalo Atomics@MattLoszak·Aug 25

Someone should make a game where you have to restart a 50 year old industry in a civilization that has forgotten how to build big things by mass-manufacturing stainless steel vessels that can magically generate billions in revenue when you put cosmically-born spicy rocks in them, all with the goal of maintaining AI supremacy in the west, while lowering the cost of electricity far enough to bring nations out of energy poverty and supply abundance to the world

i made a game where you literally have to separate the wheat from the chaff the catch is there are 10,000,000 pieces and you have to sort every single one

0:53